Amatuximab (MORAb-009)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amatuximab (MORAb-009), covering 2016-09-30 to 2016-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]